15-51724892-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_153374.3(LYSMD2):c.503C>T(p.Pro168Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,461,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_153374.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LYSMD2 | NM_153374.3 | c.503C>T | p.Pro168Leu | missense_variant | 2/3 | ENST00000267838.7 | NP_699205.1 | |
LYSMD2 | NM_001143917.2 | c.230C>T | p.Pro77Leu | missense_variant | 2/3 | NP_001137389.1 | ||
LYSMD2 | NM_001363969.2 | c.230C>T | p.Pro77Leu | missense_variant | 2/3 | NP_001350898.1 | ||
LYSMD2 | XM_047432340.1 | c.272C>T | p.Pro91Leu | missense_variant | 2/3 | XP_047288296.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LYSMD2 | ENST00000267838.7 | c.503C>T | p.Pro168Leu | missense_variant | 2/3 | 1 | NM_153374.3 | ENSP00000267838.3 | ||
LYSMD2 | ENST00000454181.6 | c.230C>T | p.Pro77Leu | missense_variant | 2/3 | 1 | ENSP00000410424.2 | |||
LYSMD2 | ENST00000560491.2 | c.230C>T | p.Pro77Leu | missense_variant | 2/3 | 3 | ENSP00000453933.1 | |||
LYSMD2 | ENST00000558126.1 | c.182C>T | p.Pro61Leu | missense_variant | 2/3 | 5 | ENSP00000452715.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461806Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727206
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2022 | The c.503C>T (p.P168L) alteration is located in exon 2 (coding exon 2) of the LYSMD2 gene. This alteration results from a C to T substitution at nucleotide position 503, causing the proline (P) at amino acid position 168 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.